Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
As the global plasmid market continues to grow rapidly, current and projected demand for high quality plasmid continues to be challenged by the availability of global supply. The Carlsbad, California site expands Thermo Fisher’s clinical and commercial capabilities for cGMP plasmid DNA used as a critical raw material to develop and manufacture cell and gene-based therapies including life-saving cancer treatments as well as mRNA vaccines.
Learn more about the specific equipment and capabilities at this site by downloading our Site Fact Sheet.